1. Home
  2. MPV vs FDMT Comparison

MPV vs FDMT Comparison

Compare MPV & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPV
  • FDMT
  • Stock Information
  • Founded
  • MPV 1988
  • FDMT 2013
  • Country
  • MPV United States
  • FDMT United States
  • Employees
  • MPV N/A
  • FDMT N/A
  • Industry
  • MPV Finance Companies
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MPV Finance
  • FDMT Health Care
  • Exchange
  • MPV Nasdaq
  • FDMT Nasdaq
  • Market Cap
  • MPV 183.8M
  • FDMT 192.2M
  • IPO Year
  • MPV N/A
  • FDMT 2020
  • Fundamental
  • Price
  • MPV $19.72
  • FDMT $4.38
  • Analyst Decision
  • MPV
  • FDMT Buy
  • Analyst Count
  • MPV 0
  • FDMT 10
  • Target Price
  • MPV N/A
  • FDMT $32.33
  • AVG Volume (30 Days)
  • MPV 25.2K
  • FDMT 538.6K
  • Earning Date
  • MPV 01-01-0001
  • FDMT 08-07-2025
  • Dividend Yield
  • MPV 8.71%
  • FDMT N/A
  • EPS Growth
  • MPV N/A
  • FDMT N/A
  • EPS
  • MPV 1.71
  • FDMT N/A
  • Revenue
  • MPV N/A
  • FDMT $23,000.00
  • Revenue This Year
  • MPV N/A
  • FDMT $13,048.65
  • Revenue Next Year
  • MPV N/A
  • FDMT N/A
  • P/E Ratio
  • MPV $9.35
  • FDMT N/A
  • Revenue Growth
  • MPV N/A
  • FDMT N/A
  • 52 Week Low
  • MPV $11.18
  • FDMT $2.24
  • 52 Week High
  • MPV $16.42
  • FDMT $28.93
  • Technical
  • Relative Strength Index (RSI)
  • MPV 63.21
  • FDMT 55.56
  • Support Level
  • MPV $18.83
  • FDMT $3.68
  • Resistance Level
  • MPV $20.35
  • FDMT $4.40
  • Average True Range (ATR)
  • MPV 0.61
  • FDMT 0.27
  • MACD
  • MPV 0.06
  • FDMT -0.02
  • Stochastic Oscillator
  • MPV 66.49
  • FDMT 59.57

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: